plerixafor has been researched along with MS (Multiple Sclerosis) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, BP; Klein, RS; Patel, JR; Williams, JL | 1 |
| Flügel, A; Miljković, D; Momcilović, M; Mostarica-Stojković, M; Odoardi, F; Stanojević, Z | 1 |
2 other study(ies) available for plerixafor and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Topics: Analysis of Variance; Animals; Axons; Benzylamines; Blotting, Western; Bromodeoxyuridine; Central Nervous System; Cyclams; Heterocyclic Compounds; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Real-Time Polymerase Chain Reaction; Receptors, CXCR; Receptors, CXCR4; Stem Cells | 2014 |
CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats.
Topics: Animals; Benzylamines; CD11b Antigen; CD4 Antigens; Chemokine CXCL12; Cyclams; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Gene Expression; Heterocyclic Compounds; Immunization; Interferon-gamma; Interleukin-17; Multiple Sclerosis; Rats; Rats, Inbred Strains; Species Specificity; Spinal Cord; T-Lymphocytes; Tissue Extracts | 2011 |